Cetera Investment Advisers
IRWD icon

Cetera Investment Advisers’s Ironwood Pharmaceuticals IRWD Stock Holding History

Cetera Investment Advisers’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.2K Buy
15,005
+3,056
+26% +$11.8K ﹤0.01% 4741
2026
Q1 		$41.9K Hold
11,949
– – ﹤0.01% 4596
2025
Q4 		$40.3K Hold
11,949
– – ﹤0.01% 4531
2025
Q3 		$15.7K Buy
+11,949
New +$12.4K ﹤0.01% 4504

Other funds holding IRWD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Cetera Investment Advisers's IRWD Position: Q2 2026 in Review

Cetera Investment Advisers increased its Ironwood Pharmaceuticals (IRWD) stake by 26% in Q2 2026, buying an estimated $11.8K and bringing the position to 15,005 shares worth $63.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4741.

Cetera Investment Advisers first reported a position in IRWD in Q3 2025 and has held it in 4 quarters since. 212 funds tracked by Wall St. Rank hold IRWD as of Q2 2026.

  • Cetera Investment Advisers held 15,005 shares of Ironwood Pharmaceuticals worth $63.2K as of Q2 2026.
  • Cetera Investment Advisers bought 3,056 Ironwood Pharmaceuticals shares in Q2 2026, an estimated $11.8K.
  • Ironwood Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4741 holding.
  • Cetera Investment Advisers first reported a position in Ironwood Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 212 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.